November 28, 2016 - By Richard Conner · 0 Comments
The stock of Bovie Medical Corporation (NYSEMKT:BVX) registered an increase of 27.22% in short interest. BVX’s total short interest was 644,000 shares in November as published by FINRA. Its up 27.22% from 506,200 shares, reported previously. With 160,400 shares average volume, it will take short sellers 4 days to cover their BVX’s short positions. The short interest to Bovie Medical Corporation’s float is 3.21%. About 21,714 shares traded hands. Bovie Medical Corporation (NYSEMKT:BVX) has risen 131.18% since April 25, 2016 and is uptrending. It has outperformed by 125.17% the S&P500.
Bovie Medical Corporation is an energy medical device company. The company has a market cap of $124.04 million. The Firm is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It currently has negative earnings. It operates through three divisions: Core, OEM and J-Plasma.
Insitutional Activity: The institutional sentiment increased to 2.44 in Q2 2016. Its up 1.90, from 0.54 in 2016Q1. The ratio is positive, as 7 funds sold all Bovie Medical Corporation shares owned while 6 reduced positions. 2 funds bought stakes while 5 increased positions. They now own 4.70 million shares or 6.35% less from 5.02 million shares in 2016Q1.
Oppenheimer accumulated 10,400 shares or 0% of the stock. Kennedy Cap has invested 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX). Manufacturers Life Insur The last reported 2,283 shares in the company. Salem Invest Counselors holds 0.01% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX) for 29,771 shares. Moreover, Royal State Bank Of Canada has 0% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 1,000 shares. Bancorp Of America Corp De accumulated 102 shares or 0% of the stock. Deutsche Bank & Trust Ag last reported 0% of its portfolio in the stock. Moreover, Vsr Fincl Service has 0.01% invested in Bovie Medical Corporation (NYSEMKT:BVX) for 19,250 shares. Dimensional Fund Advisors L P holds 0% of its portfolio in Bovie Medical Corporation (NYSEMKT:BVX) for 278,943 shares. California Pub Employees Retirement System accumulated 0% or 28,177 shares. Wasatch Advsr Inc owns 340,000 shares or 0.01% of their US portfolio. Creative Planning holds 0% or 1,475 shares in its portfolio. Blackrock Institutional Tru Com Na has 12,139 shares for 0% of their US portfolio. Geode Ltd last reported 73,582 shares in the company. Great Point Partners Limited Liability Company reported 2.68 million shares or 1.26% of all its holdings.
Insider Transactions: Since August 17, 2016, the stock had 1 buying transaction, and 0 selling transactions for $299,475 net activity. McCarthy John J. III had bought 90,750 shares worth $299,475.
Bovie Medical Corporation (Bovie), incorporated on December 3, 1982, is an energy medical device company. The Firm is also engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. The Firm operates through three divisions: Core, OEM and J-Plasma. The Firm is engaged in developing, manufacturing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor’s offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit (ESU), a handpiece and a supply of helium gas. The Company’s medical devices are marketed through its own brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. The Firm offers its products in three categories: electrosurgery, cauteries and other products.
More news for Bovie Medical Corporation (NYSEMKT:BVX) were recently published by: Businesswire.com, which released: “Bovie Medical to Present at 28th Annual Piper Jaffray Healthcare Conference” on November 23, 2016. Seekingalpha.com‘s article titled: “Bovie Medical Corporation’s (BVX) CEO Rob Gershon on Q3 2016 Results …” and published on October 27, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Richard Conner